BioLife Solutions Investor Relations Material
Latest events
Q4 2023
BioLife Solutions
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from BioLife Solutions Inc
Access all reports
BioLife Solutions, Inc., a development stage company, develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. It offers preservation media products that are serum-free solutions used to store and transport cells in the research laboratory setting; thawing media products; CryoStor freeze media products that are human plasma-based solutions used by customers to cryopreserve cells during cell banking; HypoThermosol storage media products that are human plasma-based solutions for shipping cells at controlled temperatures; and custom manufacturing services. The company also offers Platelet Lysate products that are human platelet-derived preparations to replace fetal bovine serum in cell culture media.
Latest articles
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States